Vincerx Pharma Statistics Share Statistics Vincerx Pharma has 5.23M
shares outstanding. The number of shares has increased by 51.66%
in one year.
Shares Outstanding 5.23M Shares Change (YoY) 51.66% Shares Change (QoQ) 22.83% Owned by Institutions (%) 0.03% Shares Floating 4.67M Failed to Deliver (FTD) Shares 205 FTD / Avg. Volume 0.02%
Short Selling Information The latest short interest is 2K, so 0.04% of the outstanding
shares have been sold short.
Short Interest 2K Short % of Shares Out 0.04% Short % of Float 0.04% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.33 and the forward
PE ratio is -0.01.
Vincerx Pharma's PEG ratio is
0.
PE Ratio -0.33 Forward PE -0.01 PS Ratio 0 Forward PS 0 PB Ratio 3.67 P/FCF Ratio -0.38 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Vincerx Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.21,
with a Debt / Equity ratio of 0.
Current Ratio 1.21 Quick Ratio 1.21 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.51M Employee Count 12 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -99.65% in the
last 52 weeks. The beta is 1.48, so Vincerx Pharma's
price volatility has been higher than the market average.
Beta 1.48 52-Week Price Change -99.65% 50-Day Moving Average 0.18 200-Day Moving Average 4.77 Relative Strength Index (RSI) 32.44 Average Volume (20 Days) 826,320
Income Statement
Revenue n/a Gross Profit n/a Operating Income -31.46M Net Income -30.07M EBITDA -31.46M EBIT n/a Earnings Per Share (EPS) -15.85
Full Income Statement Balance Sheet The company has 4.99M in cash and 0 in
debt, giving a net cash position of 4.99M.
Cash & Cash Equivalents 4.99M Total Debt n/a Net Cash n/a Retained Earnings -189.19M Total Assets 4.69M Working Capital 2.07M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -26.13M
and capital expenditures 0, giving a free cash flow of -26.13M.
Operating Cash Flow -26.13M Capital Expenditures n/a Free Cash Flow -26.13M FCF Per Share -13.77
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields VINC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for VINC is $40,
which is 79900% higher than the current price. The consensus rating is "Buy".
Price Target $40 Price Target Difference 79900% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 28, 2025. It was a
backward
split with a ratio of 1:20.
Last Split Date Jan 28, 2025 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -76.67 Piotroski F-Score 2
